JESSIE MAYNE: Open Payments
NPI 1134513369 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 25 payments from 13 companies in 2025. Trend: 2023 $494 · 2024 $691 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $238 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Bausch Health US, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Azstarys, FANAPT, INGREZZA, Qelbree, Auvelity, LYBALVI, SPRAVATO, APLENZIN.
Industry payments across SC — which companies pay providers there.
